Max Healthcare to acquire 58.39% in Kalinga Hospital for Rs 300 Cr

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹933.50

prior close

₹945.00

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+3.9%-3.2% vs market

Hospital peers, median of 24sector+2.5%-1.8% vs sector

On the reaction day the stock moved 3.2 pts less than Nifty 100 and 1.8 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.1

15m

-0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8+3.9-3.2+2.5-1.8

Next day

+2.2+3.2-1.0+2.5-0.4

+2.5+4.5-2.0+4.1-1.6

+1.8+3.7-1.9+2.5-0.7

+6.1+5.5+0.6+4.5+1.6

+6.2+5.5+0.7+3.6+2.6

+8.1+6.4+1.6+5.8+2.2

15d

+6.3+4.9+1.4+8.0-1.8

+8.5+6.1+2.5+12.7-4.2

+7.8+1.6+6.2+14.3-6.5

+16.2+4.9+11.3+16.5-0.4

UpDownMarket · Nifty 100Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare's board approved acquiring ~58.39% stake in 250-bed Kalinga Hospital (Bhubaneswar) for ~Rs 300 Cr cash. KHL reported FY25 revenue of ~Rs 135.6 Cr. Max will provide Rs 100 Cr loan to KHL and $5 Mn corporate guarantee. Funded via Rs 300 Cr ECB from StanChart. Adds 250 beds to Max's ~5,200-bed network, marking its Eastern India foray. Director N.K. Seshadri re-appointed for 3 years.

Likely market impact

Expands Max's footprint into Eastern India with a revenue-generating hospital. Debt-funded; near-term EPS dilution likely until integration.